快猫短视频

Skip to main content

What's New in Chronic Myelomonocytic Leukemia Research and Treatment?

Research into the causes, diagnosis, and treatment of chronic myelomonocytic leukemia (CMML) is being done at many cancer research centers. CMML has been hard to study, because it isn't common, and because it's taken researchers many years to determine what makes it different from other blood diseases. But scientists continue to make progress in understanding this disorder.

Genetics?

Researchers? are learning more about which changes in a person's DNA (the substance that makes up our genes) can cause normal bone marrow cells to develop into leukemia cells. Studies have found that changes in the structure or activity of certain genes in CMML cells may help predict a person's outcome and how likely they are to go on to develop acute leukemia. Researchers are also hoping that finding some of the gene changes in CMML cells might lead to treatments that target these changes (see below).

Chemotherapy and other drugs

Studies are in progress to find which chemotherapy drugs can help treat CMML, while trying to limit side effects. New drugs are continually being developed and tested.

As researchers have learned more about what makes cancer cells different from normal cells, they've developed drugs that target these differences. Studies are now looking at some of these targeted therapies to treat CMML. These drugs target things like specific cell signaling pathways to shut down CMML cell growth.

Stem cell transplant

Scientists continue to refine stem cell transplants so that they work better and cause fewer problems. They are also looking at which patients will benefit the most and how newer transplant methods might be used to treat CMML.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.

 

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Myelodysplastic Syndromes. Version 1.2024. Accessed at https://www.nccn.org on May 18, 2024. 

Padron E, Gurbuxani S. Chronic myelomonocytic leukemia: Clinical features, evaluation, and diagnosis. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/chronic-myelomonocytic-leukemia-clinical-features-evaluation-and-diagnosis on May 18, 2024.

Padron E. Chronic myelomonocytic leukemia: Management and prognosis. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/chronic-myelomonocytic-leukemia-management-and-prognosis on May 18, 2024.

 

Last Revised: May 21, 2024

American Cancer Society Emails

Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.